News
Atinary & Chemspeed launched their Demo Lab in Basel, showcasing AI and robotics for autonomous R&D, augmenting scientists and accelerating discovery.
Atinary collaborates with ABB Robotics, Mettler-Toledo, and Agilent to launch the first Self-Driving Lab of its kind in accelerating molecular discovery.
Atinary announces availability of its SDLabs platform in AWS Marketplace.
Atinary’s SDLabs Platform is now SOC 2 compliant, ensuring top security, availability, and trust for scientists and R&D teams worldwide.
Atinary and Amazon Web Services (AWS) partner to accelerate AI-driven R&D and Scientific Discovery.
Atinary welcomes Dr. Stephen Buchwald, pioneering chemist behind Buchwald–Hartwig reaction, to advance AI-driven molecular discovery and innovation.
Atinary and Chemspeed are teaming up to accelerate R&D with AI and automation. Their no-code AI and automation platforms are now fully integrated, enabling self-driving labs with closed-loop optimization. Live demos launch in Basel (Q3 2025) and Boston (Q4 2025), showcasing faster, smarter experimentation.
Atinary and Dr. Angelo Frei’s lab at the University of York secure funding to revolutionize metalloantibiotic discovery, leveraging AI and high-throughput screening to combat antimicrobial resistance.
Atinary welcomes Professor Philippe Schwaller to its Scientific Advisory Board to advance AI-driven molecular discovery and Self-Driving Labs™ technology.
Atinary collaborates with the lab of Prof. Rogelio Hernández-López at Stanford University to advance T cell engineering using AI, optimizing synthetic circuits for safer, more effective cell therapies.
